Priority Date: 21.12.07 (BR 2007PI04860)

UTILIZATION OF MODIFIED VACCINIA ANKARA VIRUS (MVA) WITH GENES THAT ENCODE FOR THE TOXOPLASMA GONDII SAG1 SURFACE PROTEIN, AS VACCINES AGAINST TOXOPLASMOSIS

  • Application ID: EP08864038
  • Status: No opposition filed within time limit

Applicant

Research organisation logo small
Research Organisation

Attorneys

no operation time available
Headquarter in Cologne and 1 office
active in Legal Services
no operation time available
Headquarter in Cologne and 1 office
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 21.12.2007 - Priority Date (BR 2007PI04860)
  • 02.07.2009 - Publication A2 (WO2009079731)
  • 01.09.2010 - Publication A2 (EP2222332)
  • 08.06.2016 - Publication B1 (EP2222332)

IPC Classification